Skip to content

The study on the safety and effectiveness of individualized ventilation strategy used in craniotomy

The study on the safety and effectiveness of individualized ventilation strategy used in craniotomy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072166
Enrollment
Unknown
Registered
2023-06-05
Start date
2023-07-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative pulmonary complications

Interventions

Individualized ventilation group:Individualized lung protective ventilation
Traditional ventilation group:Traditional ventilation

Sponsors

Tianjin Huanhu Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Patients scheduled to receive elective intracranial tumor resection(the maximum diameter of tumor is 2-5cm); 2.age:18-70 years old,male and female; 3.American Society of Anesthesiologists(ASA)classficationI-II; 4.18.5<body mass index(BMI)<28; 5.Glasgow Coma Scale score of more than 8 points; 6.PPCs risk index(ARISCAT) score of more than 26 points;7.Expected operation time more than 4 h; 8.Having signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1.History of chronic lung disease,pulmonary infection,acute respiratory faliure or pulmonary surgery; 2.Patients with severe brain,heart,liver,or kidney diseases; 3.Patients with preoperative nerve injury affecting breathing,or dysphagia; 4.Pregnant women; 5.Those who refuse to participate in the research.

Design outcomes

Primary

MeasureTime frame
Intracranial pressure;Cerebral perfusion pressure;Incidence of postoperative pulmonary complications;

Secondary

MeasureTime frame
Brain relaxation score;Lung recruitment;Severity of postoperative pulmonary complications;Adverse effects during operation;Oxygenation index;Intraoperative blood loss;Inflammatory cytokines;Length of ICU stay;

Countries

China

Contacts

Public ContactZhang Hongtao

Tianjin Huanhu Hospital

zhtao80@163.com+86 22 5906 5919

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026